George M. Milne

George M. Milne, Jr., Ph.D. became a Radius Venture Partner in 2002. From 1993 to 2000, Dr. Milne served as President of Central Research for Pfizer, Inc. and oversaw both human and veterinary research and development. Following Pfizer’s merger with Warner Lambert, he held the position of Executive Vice President of Global Research and Development and also served as President of Strategic and Operations Management.

Dr. Milne serves on the board of directors of several Radius portfolio companies, including Athersys, Inc., BioStorage Technologies, Inc., Resolvyx Pharmaceuticals, Inc., and Rib-X Pharmaceuticals, Inc. and previously served on the board of Conor Medsystems, Inc. Dr. Milne also currently serves on the board of directors of Mettler-Toledo, Inc., Charles River Laboratories, Inc., the Mystic Aquarium-Institute for Exploration and the New York Botanical Garden.

Dr. Milne received a B.S. in Chemistry from Yale University and a Ph.D. in Organic Chemistry from the Massachusetts Institute of Technolog

George M. Milne is the Venture Partner at Radius Ventures. With a background in Financial Services, George M. Milne has a rich history of leadership and innovation. George M. Milne studied BS Chemistry @ Yale University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.